150 related articles for article (PubMed ID: 365313)
1. Cyclophosphamide (NSC 26271) versus the combination of adriamycin (NSC 123127), 5-fluorouracil (NSC 19893), and cyclophosphamide in the treatment of metastatic prostatic cancer: a randomized trial.
Chlebowski RT; Hestorff R; Sardoff L; Weiner J; Bateman JR
Cancer; 1978 Dec; 42(6):2546-52. PubMed ID: 365313
[TBL] [Abstract][Full Text] [Related]
2. Adriamycin (NSC-123127) versus 5-fluorouracil (NSC-19893) and cyclophosphamide (NSC-26271) in the treatment of metastatic prostate cancer.
Eagan RT; Hahn RG; Myers RP
Cancer Treat Rep; 1976 Jan; 60(1):115-7. PubMed ID: 1000515
[No Abstract] [Full Text] [Related]
3. Comparison of adriamycin (NSC-123127) and the combination of 5-fluorouracil (NSC-19893) and cyclophosphamide (NSC-26271) in advanced prostatic cancer: a preliminary report.
Eagan RT; Utz DC; Myers RP; Furlow WL
Cancer Chemother Rep; 1975; 59(1):203-7. PubMed ID: 1093666
[TBL] [Abstract][Full Text] [Related]
4. Low dose chemotherapy of metastatic breast cancer with cyclophosphamide, adriamycin, methotrexate, 5-fluorouracil (CAMF) versus sequential cyclophosphamide, methotrexate, 5-fluorouracil (CMF) and adriamycin.
Creech RH; Catalano RB; Harris DT; Engstrom PF; Grotzinger PJ
Cancer; 1979 Jan; 43(1):51-9. PubMed ID: 367574
[TBL] [Abstract][Full Text] [Related]
5. Combination chemotherapy for advanced breast cancer: two regimens containing adriamycin.
Kennealey GT; Boston B; Mitchell MS; Knobf MK; Bobrow SN; Pezzimenti JF; Lawrence R; Bertino JR
Cancer; 1978 Jul; 42(1):27-33. PubMed ID: 667798
[TBL] [Abstract][Full Text] [Related]
6. Combination of adriamycin and cyclophosphamide in the treatment of metastatic prostatic carcinoma: a phase II study.
Izbicki RM; Amer MH; Al-Sarraf M
Cancer Treat Rep; 1979 Jun; 63(6):999-1001. PubMed ID: 380805
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy of advanced carcinoma of the prostate with 5-fluorouracil, cyclophosphamide and adriamycin.
Merrin C; Etra W; Wajsman Z; Baumgartner G; Murphy G
J Urol; 1976 Jan; 115(1):86-8. PubMed ID: 1107604
[TBL] [Abstract][Full Text] [Related]
8. Cyclophosphamide versus 5-fluorouracil, doxorubicin, and mitomycin C (FAM') in the treatment of hormone-resistant metastatic carcinoma of the prostate: a preliminary report of a randomized trial.
Kasimis BS; Miller JB; Kaneshiro CA; Forbes KA; Moran EM; Metter GE
J Clin Oncol; 1985 Mar; 3(3):385-92. PubMed ID: 3838343
[TBL] [Abstract][Full Text] [Related]
9. Hormone-refractory metastatic prostatic cancer treated with methotrexate, cyclophosphamide plus adriamycin, cis-platinum plus 5-fluorouracil plus cyclophosphamide. National Prostatic Cancer Project randomized trial.
Murphy GP; Priore RL; Scardino PT
Urology; 1988 Jul; 32(1):33-40. PubMed ID: 3291371
[TBL] [Abstract][Full Text] [Related]
10. Treatment of advanced colon cancer with 5-fluorouracil (NSC19893) versus cyclophosphamide (NSC26271) plus 5-fluorouracil: prognostic aspects of the differential white blood cell count.
Chlebowski RT; Silverberg I; Pajak T; Weiner J; Kardinal C; Bateman JR
Cancer; 1980 May; 45(9):2240-4. PubMed ID: 6991095
[TBL] [Abstract][Full Text] [Related]
11. A phase II evaluation of a 3-drug combination of cyclophosphamide, doxorubicin and 5-fluorouracil and of 5-fluorouracil in patients with advanced bladder carcinoma or stage D prostatic carcinoma.
Smalley RV; Bartolucci AA; Hemstreet G; Hester M
J Urol; 1981 Feb; 125(2):191-5. PubMed ID: 7206052
[TBL] [Abstract][Full Text] [Related]
12. Doxorubicin hydrochloride, cyclophosphamide, and 5-fluorouracil combination in advanced prostate and transitional cell carcinoma.
Collier D; Soloway MS
Urology; 1976 Nov; 8(5):459-64. PubMed ID: 982733
[TBL] [Abstract][Full Text] [Related]
13. Combination chemotherapy with methotrexate (NSC-740), adriamycin (NSC-123127), cyclophosphamide (NSC-26271), and 5-fluorouracil (NSC19893) for adult solid tumors.
Stephens RL; Hoogstraten B
Cancer Chemother Rep; 1974; 58(6):943-5. PubMed ID: 4614901
[No Abstract] [Full Text] [Related]
14. Cyclophosphamide, methotrexate and 5-fluorouracil combination chemotherapy versus chloroethyl-cyclohexy-nitrosourea in the treatment of metastatic prostatic cancer.
Herr HW
J Urol; 1982 Mar; 127(3):462-5. PubMed ID: 7062419
[TBL] [Abstract][Full Text] [Related]
15. Combination chemotherapy with cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) in advanced breast carcinoma.
Dalley DN; Levi JA; Aroney RS
Med J Aust; 1980 Mar; 1(5):216-8. PubMed ID: 6990214
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy of advanced measurable colon and rectal carcinoma with oral 5-fluorouracil, alone or in combination with cyclophosphamide or 6-thioguanine, with intravenous 5-fluorouracil or beta-2'-deoxythioguanosine or with oral 3(4-methyl-cyclohexyl)-1(2-chlorethyl)-1-nitrosourea: a Phase II-III study of the Eastern Cooperative Oncology Group (EST 4273).
Douglass HO; Lavin PT; Woll J; Conroy JF; Carbone P
Cancer; 1978 Dec; 42(6):2538-45. PubMed ID: 365312
[TBL] [Abstract][Full Text] [Related]
17. Combination chemotherapy with adriamycin (NSC-123127) and cyclophosphamide (NSC-26271) for solid tumors: a phase II trial.
Lloyd RE; Jones SE; Salmon SE; Durie BG; McMahon LJ
Cancer Treat Rep; 1976 Jan; 60(1):77-83. PubMed ID: 1000520
[TBL] [Abstract][Full Text] [Related]
18. cis-Dichlorodiammineplatinum(II) alone followed by adriamycin plus cyclophosphamide at progression versus cis-dichlorodiammineplatinum(II), adriamycin, and cyclophosphamide in combination for adenocarcinoma of the lung.
Britell JC; Eagan RT; Ingle JN; Creagen ET; Rubin J; Frytak S
Cancer Treat Rep; 1978 Aug; 62(8):1207-10. PubMed ID: 688256
[TBL] [Abstract][Full Text] [Related]
19. Adriamycin and Cytoxan in the treatment of inoperable lung cancer.
Hoeltgen TM; MacIntyre JM; Perlia CP; Lagakos SW; Stolbach LL; Bennett JM
Cancer; 1983 Jun; 51(11):2005-12. PubMed ID: 6301671
[TBL] [Abstract][Full Text] [Related]
20. Cyclophosphamide, doxorubicin hydrochloride and 5-fluorouracil in advanced carcinoma of the prostate.
Soloway MS; Shippel RM; Ikard M
J Urol; 1979 Nov; 122(5):637-9. PubMed ID: 501816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]